Atlas Trials

The Effects of Empagliflozin on Renal Outcomes in Post Severe Acute Kidney Injury Survivors

Clinical trial NCT05360615 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05360615
Sponsor
Chulalongkorn University
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Empagliflozin in Post AKI Stage 2-3
Start date
2022-07-01
Primary completion
2024-06-01
Enrollment
147

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.